soul semaglutide trial oral cardiovascular outcomes 2024 2025 Oral Semaglutide Reduces Cardiovascular Events in People with soul study semaglutide SOUL: Oral

How does functional medicine approach OCD, and what natural strategies can help

GRAS status as a food ingredient

In the STEP 1 trial 23 , the mean change in body weight from baseline to 68 weeks was 14.9%, compared with 2.4% with placebo

Last reviewed: May 14, 2026 Last updated: May 14, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

We offer a holistic plan to support your well-being with prescription medication, lifestyle content, and a nutrition plan tailored to your unique needs